利钠肽受体可分为 NPR-A、NPR-B(鸟苷酸环化酶-A和鸟苷酸环化酶-B)和 NPR-C 三种类型,三种受体均对生物第二信使有作用。NPR-A 和 NPR-B 为鸟苷酸环化酶受体,其激活可导致 cGMP 水平升高,而 NPR-C 的激活可导致腺苷酸环化酶活性被抑制、磷脂酶 C 活性升高。利钠肽受体在血压和心血管稳态调节中起重要作用。
Natriuretic peptide receptors can be divided into three types: NPR-A, NPR-B (guanylate cyclase-A and guanylate cyclase-B) and NPR-C. All three receptors have an effect on biological second messengers. NPR-A and NPR-B are guanylate cyclase receptors, and their activation can lead to increased cGMP levels, while the activation of NPR-C can lead to the inhibition of adenylate cyclase activity and increased phospholipase C activity. Natriuretic peptide receptors play an important role in the regulation of blood pressure and cardiovascular homeostasis[1].
A 71915 是一种高效、竞争性的 natriuretic peptide receptor A (ANP, NPRA) 拮抗剂(pKi=9.18),可以剂量依赖性方式取代 [125I]ANP(Ki=0.65 nM),并对大鼠 ANP 诱导的 NB-OK-1 细胞 cGMP 生成具有拮抗作用(pA2=9.48)。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号